NCT01698060View on ClinicalTrials.gov

Immunogenicity of ND1.1 by Delivery Directly to the Ileum

PHASE1CompletedINTERVENTIONAL
Enrollment

12

Participants

Timeline

Start Date

September 30, 2012

Primary Completion Date

November 30, 2013

Study Completion Date

November 30, 2013

Conditions
Avian Influenza
Interventions
BIOLOGICAL

ND1.1

Trial Locations (1)

Unknown

Scintipharma, Lexington

Sponsors

Lead Sponsor

Vaxart
All Listed Sponsors
lead

Vaxart

INDUSTRY

NCT01698060 - Immunogenicity of ND1.1 by Delivery Directly to the Ileum | Biotech Hunter | Biotech Hunter